Roles of PPARS in health and disease

Nature

Volumn 405, Issue 6785, 2000, Pages 421-424

  Kersten, Sander ^a   Desvergne, Béatrice ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; THIAZOLE DERIVATIVE;

ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; GENE ACTIVITY; GENE CONTROL; GENE FUNCTION; GENE TARGETING; MOLECULAR GENETICS; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; CHRONIC DISEASE; GENE TARGETING; HUMANS; LIGANDS; METABOLIC DISEASES; NEOPLASMS; NUTRITIONAL STATUS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0034713444     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35013000     Document Type: Article

References (30)

1. Desvergene, B. & Wahli, W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649-688 (1999).
2. Lin, Q., Ruuska, S. E., Shaw, N. S., Dong, D. & Noy, N. Ligand selectivity of peroxisome proliferator activated receptor alpha. Biochemistry 38, 185-190 (1999).
3. Ellinghaus, P., Wolfrum, C., Assmann, G., Spencer, F. & Seedorf, U. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/sterol carrier protein x-deficient mite. J. Biol. Chem. 274, 2766-2772 (1999).
4. Moya-Camarena, S. Y., Vanden Heuvel, J. P., Blanchard, S. G., Leesnitzer, L. A. & Belury, M. A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res. 40, 426-1433 (1999).
5. Rosen, E. D. et al. PPAR is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4, 611-617 (1999).
6. Basu-Modak, S. et al. Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures. J. Biol. Chem. 274, 35881-35888 (1999).
7. Lim, H. et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 13, 1561-1574 (1999).
8. Foretz, M. et al. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19, 3760-3768 (1999).
9. Foretz, M., Guichard, C., Ferre, P. & Foufelle, F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic, expression of glucokinase and lipogenesis-related genes. Proc. Natl Acad. Sci. USA 96, 12737-12742 (1999).
10. Rieusset, J. et al. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes 48, 699-705 (1999).
11. Fajas, L. et al. Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol. Cell. Biol. 19, 5495-5503 (1999).
12. Wang, M. Y., Lee, Y. & Unger, R. H. Novel form of lipolysis induced by leptin. J. Biol. Chem. 274, 17541-17544 (1999).
13. Kubota, N. et al. PPAR mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4, 597-609 (1999).
14. Kersten, S. et al. Peroxisome proliferator activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489-1498 (1999).
15. Leone, T. C., Weinheimer, C. J. & Kelly, D. P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl Acad. Sci. USA 96, 7473-7478 (1999).
16. Wang, M., Wise, S. C., Leff, T. & Su, T. Z. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma. Diabetes 48, 254-260 (1999).
17. Kockx, M. F. et al. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha. Blood 93, 2991-2998 (1999).
18. Devchand, P. R. et al. Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4). J. Biol. Chem. 274, 23341-23348 (1999).
19. Delerive, P. et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NH-kappaB and AP-1. J. Biol. Chem. 274, 32048-32054 (1999).
20. Hill, M. R. et al. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia Infect. Immun. 67, 3488-3493 (1999).
21. Ricote, M., Huang, J. T., Welch, J. S. & Glass, C. K. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function. J. Leukoc. Biol. 66, 733-739 (1999).
22. Thieringer, R. et al. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro and in vivo. J. Immunol. 164, 1046-1054 (2000).
23. Demetri, G. D. et al. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc. Natl Acad. Sci. USA 96, 3951-3956 (1999).
24. Suh, N. et al. A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. Cancer Res. 59, 5671-5673 (1999).
25. He, T. C., Chan, T. A., Vogelstein, B. & Kinzler, K. W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335-345 (1999).
26. Barak, Y. et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4, 585-595 (1999).
27. Valve, R. et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J. Clin. Endocrinol. Metab. 84, 3708-3712 (1999).
28. Ek, J. et al. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42, 892-895 (1999).
29. Mancini, F. P. et al Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes 48, 1466-1468 (1999).
30. Barroso, I. et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880-883 (1999).